Fundz

Lexaria Bioscience Corp. Appoints Michael Shankman as Chief Financial Officer

PUBLIC · LEXXOct 01, 2024

Position

Chief Financial Officer

Company

Lexaria Bioscience

Michael Shankman
mshankman@lexariabioscience.com
KelownaOtherBiotechnologyHealthcare

Description

Lexaria Bioscience Corp announces the appointment of Michael Shankman, CPA, as Chief Financial Officer (CFO) effective immediately. Mr Shankman will lead the Company's financial operations, bringing a wealth of financial and regulatory knowledge and experience to the executive team.

Quick answer

Lexaria Bioscience Corp. Appoints Michael Shankman as Chief Financial Officer (October 1, 2024). Lexaria Bioscience is based in Kelowna, British Columbia, Canada.

Who is the new Chief Financial Officer at Lexaria Bioscience?
Lexaria Bioscience named Michael Shankman Chief Financial Officer, announced October 1, 2024.
What did Lexaria Bioscience announce on October 1, 2024?
Lexaria Bioscience Corp announces the appointment of Michael Shankman, CPA, as Chief Financial Officer (CFO) effective immediately. Mr Shankman will lead the Company's financial operations, bringing a wealth of financial and regulatory knowledge and experience to the executive team.
What does Lexaria Bioscience do?
Lexaria Bioscience Corp. is a global innovator in drug delivery platforms, focusing on improving the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery.
Where is Lexaria Bioscience based?
Lexaria Bioscience is based in Kelowna, British Columbia, Canada.
Which similar companies made leadership changes around the same time?
Century Therapeutics (September 27, 2024), Nuvation Bio (October 7, 2024), UroGen Pharma (October 9, 2024) and Amwell (October 16, 2024) also announced leadership changes within 45 days of Lexaria Bioscience.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Lexaria Bioscience, and when

A new leader at Lexaria Bioscience brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Lexaria Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lexaria Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lexaria Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lexaria Bioscience

Location

100 - 740 MCCURDY ROAD

Kelowna, British Columbia, Canada

About

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms, focusing on improving the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. The company has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats, and operates a licensed in-house research laboratory. Additionally, the company holds a robust intellectual property portfolio with 39 patents granted and many patents pending worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lexaria Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

George
Senior decision-maker at this company
••••••••@••••••••

See George's verified email →

Vanessa
Senior decision-maker at this company
••••••••@••••••••

See Vanessa's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Lexaria Bioscience's next move

Learn about Strategic plan

Lexaria Bioscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.